Published in Vaccine on July 29, 2011
Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion. Front Microbiol (2016) 0.80
Glycosylated and nonglycosylated complement control protein of the lister strain of vaccinia virus. Clin Vaccine Immunol (2014) 0.75
Species specificity of vaccinia virus complement control protein towards bovine classical pathway is governed primarily by direct interaction of its acidic residues with factor I. J Virol (2017) 0.75
Preparation of monoclonal antibodies: strategies and procedures. Methods Enzymol (1981) 14.45
The complement system in regulation of adaptive immunity. Nat Immunol (2004) 4.58
Complement evasion by human pathogens. Nat Rev Microbiol (2008) 4.24
Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell (2006) 3.83
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity (2008) 3.36
Poxvirus tropism. Nat Rev Microbiol (2005) 3.07
Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc Natl Acad Sci U S A (2002) 2.95
Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature (1988) 2.63
Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science (1990) 2.49
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology (2005) 2.36
Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A (1992) 2.12
Vaccinia virus immune evasion. Immunol Rev (1997) 2.03
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A (1998) 1.97
Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med (2001) 1.91
Cowpox virus infection: an emerging health threat. Curr Opin Infect Dis (2008) 1.85
Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans. Cell (2001) 1.80
Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway. J Immunol (1998) 1.49
Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement. J Virol (2008) 1.49
Regulation of complement activity by vaccinia virus complement-control protein. J Infect Dis (1992) 1.49
Re-emergence of human monkeypox in Zaire in 1996. Monkeypox Epidemiologic Working Group. Lancet (1997) 1.45
The genomic sequence of ectromelia virus, the causative agent of mousepox. Virology (2003) 1.33
Complement and viral pathogenesis. Virology (2011) 1.32
Microbial subversion of the immune response. Proc Natl Acad Sci U S A (2002) 1.31
Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement. Virology (2004) 1.21
Smallpox vaccines: targets of protective immunity. Immunol Rev (2011) 1.21
Structure and regulatory profile of the monkeypox inhibitor of complement: comparison to homologs in vaccinia and variola and evidence for dimer formation. J Immunol (2006) 1.21
The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology (1997) 1.17
Complement-opsonized HIV: the free rider on its way to infection. Mol Immunol (2005) 1.09
Viral mimicry of the complement system. J Biosci (2003) 1.08
Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). Mol Immunol (1999) 1.08
Monkeypox virus and insights into its immunomodulatory proteins. Immunol Rev (2008) 1.07
Surviving mousepox infection requires the complement system. PLoS Pathog (2008) 1.07
Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity. J Immunol (2009) 1.03
Solution structure and dynamics of the central CCP module pair of a poxvirus complement control protein. J Mol Biol (2001) 1.03
Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. J Virol (2008) 1.02
Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J Virol (2004) 1.00
Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection. J Virol (2003) 1.00
Complement, viruses, and virus-infected cells. Springer Semin Immunopathol (1983) 1.00
Identification of complement regulatory domains in vaccinia virus complement control protein. J Virol (2005) 0.98
Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein. J Virol (2003) 0.97
Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack. J Virol (2008) 0.97
Herpes and pox viral complement control proteins: 'the mask of self'. Trends Immunol (2003) 0.94
Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding. J Immunol (2000) 0.93
Functional role of the noncatalytic subunit of complement C5 convertase. J Immunol (2000) 0.93
Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment. J Immunol (2008) 0.92
Species-specific differences in the structure of orthopoxvirus complement-binding protein. Virus Res (2001) 0.90
Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. Biochim Biophys Acta (2003) 0.89
The Vaccinia virus complement control protein modulates adaptive immune responses during infection. J Virol (2010) 0.88
The Th1-specific costimulatory molecule, m150, is a posttranslational isoform of lysosome-associated membrane protein-1. J Immunol (2002) 0.84
Viral complement regulators: the expert mimicking swindlers. Indian J Biochem Biophys (2007) 0.84
'Complementing' viral infection: mechanisms for evading innate immunity. Trends Microbiol (2003) 0.83
Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein. J Immunol (2010) 0.81
Co-secretion of two distinct kappa light chains by the mu-9 hybridoma. Hybridoma (1999) 0.77
[Allelic exclusion in hybridomas. I. Isolation and properties of a hybrid clone producing two allelic variants of light chain immunoglobulins in the rat]. Mol Biol (Mosk) (1984) 0.76
Two kappa immunoglobulin light chains are secreted by an anti-DNA hybridoma: implications for isotypic exclusion. Mol Immunol (1995) 0.76
Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India. PLoS One (2010) 2.15
Holliday junction processing activity of the BLM-Topo IIIalpha-BLAP75 complex. J Biol Chem (2007) 1.59
Characterization of the influenza A H5N1 viruses of the 2008-09 outbreaks in India reveals a third introduction and possible endemicity. PLoS One (2009) 1.52
Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells. Nat Immunol (2013) 1.38
The structural basis of compstatin activity examined by structure-function-based design of peptide analogs and NMR. J Biol Chem (2002) 1.10
Viral mimicry of the complement system. J Biosci (2003) 1.08
Avian influenza surveillance reveals presence of low pathogenic avian influenza viruses in poultry during 2009-2011 in the West Bengal State, India. Virol J (2012) 1.06
Studies of structure-activity relations of complement inhibitor compstatin. J Immunol (2003) 1.04
Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation. J Virol (2008) 1.02
Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J Virol (2004) 1.00
Identification of complement regulatory domains in vaccinia virus complement control protein. J Virol (2005) 0.98
Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) open reading frame 4 protein (kaposica) is a functional homolog of complement control proteins. J Virol (2003) 0.95
Herpes and pox viral complement control proteins: 'the mask of self'. Trends Immunol (2003) 0.94
The budding yeast Mei5-Sae3 complex interacts with Rad51 and preferentially binds a DNA fork structure. DNA Repair (Amst) (2011) 0.91
Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol (2005) 0.89
Functional interactions of meiotic recombination factors Rdh54 and Dmc1. DNA Repair (Amst) (2008) 0.88
Compstatin inhibits complement activation by binding to the beta-chain of complement factor 3. Mol Immunol (2006) 0.88
Role of replication protein A in double holliday junction dissolution mediated by the BLM-Topo IIIα-RMI1-RMI2 protein complex. J Biol Chem (2013) 0.86
The Th1-specific costimulatory molecule, m150, is a posttranslational isoform of lysosome-associated membrane protein-1. J Immunol (2002) 0.84
Viral complement regulators: the expert mimicking swindlers. Indian J Biochem Biophys (2007) 0.84
Functional characterization of the complement control protein homolog of herpesvirus saimiri: ARG-118 is critical for factor I cofactor activities. J Biol Chem (2006) 0.82
Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus. J Immunol (2010) 0.82
A novel CD28 mRNA variant and simultaneous presence of various CD28 mRNA isoforms in human T lymphocytes. Hum Immunol (2002) 0.82
Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein. J Immunol (2010) 0.81
Identification of Complin, a novel complement inhibitor that targets complement proteins factor B and C2. J Immunol (2010) 0.78
Dissection of functional sites in herpesvirus saimiri complement control protein homolog. J Virol (2012) 0.78
Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules. J Immunol (2012) 0.78
Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer. Oncol Res (2016) 0.77
Interleukin 23 in Crohn's disease. Inflamm Bowel Dis (2014) 0.77
Inactivation of polygalacturonase and pectate lyase produced by pH tolerant fungus Fusarium moniliforme NCIM 1276 in a liquid medium and in the host tissue. Microbiol Res (2006) 0.77
Inherent photoluminescence Stokes shift in GaAs. Opt Lett (2015) 0.75